Follow Us:

Case Law Details

Case Name : In re Nueclear Healthcare Limited (AAR Maharashtra)
Related Assessment Year :
Become a Premium member to Download. If you are already a Premium member, Login here to access.
In re Nueclear Healthcare Limited (AAR Maharashtra) Applicant is engaged in the business of manufacturing of fludeoxyglucose F 18, also commonly called FDG, radiopharmaceutical used in the medical imaging modality positron emission tomography (PET). Nueclear Healthcare Limited, the applicant, seeking an advance ruling in respect of the following questions : 1. Whether the product ‘Fludeoxyglucose’ or ‘FDG ‘ can be classifiable under Chapter 3006 3000 of the Central Excise Tariff Act, 1985 ? 2. Whether chemicals used as pharmaceuticals that are inorganic or/ and of organ...
This is premium content. Please become a Premium member. If you are already a member, login here to access the full content.

Join Taxguru’s Network for Latest updates on Income Tax, GST, Company Law, Corporate Laws and other related subjects.

Leave a Comment

Your email address will not be published. Required fields are marked *

Search Post by Date
June 2026
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930